Bruce Jackson
Stock Analyst at Benchmark
(0.92)
# 4,020
Out of 5,241 analysts
115
Total ratings
32.73%
Success rate
-17.09%
Average return
Main Sectors:
Stocks Rated by Bruce Jackson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNDM Tandem Diabetes Care | Initiates: Hold | n/a | $12.87 | - | 1 | May 12, 2026 | |
| MMED MiniMed Group | Initiates: Buy | $20 | $10.83 | +84.67% | 1 | May 12, 2026 | |
| NEO NeoGenomics | Upgrades: Buy | $11 | $8.27 | +33.01% | 9 | Apr 29, 2026 | |
| CV CapsoVision | Maintains: Speculative Buy | $14 → $10 | $6.89 | +45.14% | 3 | Mar 27, 2026 | |
| ABT Abbott Laboratories | Initiates: Buy | $145 | $84.26 | +72.09% | 1 | Oct 10, 2025 | |
| BFRI Biofrontera | Maintains: Buy | $7 → $2.75 | $0.95 | +189.41% | 8 | May 19, 2025 | |
| HUMA Humacyte | Maintains: Buy | $17 → $14 | $0.92 | +1,428.38% | 15 | May 14, 2025 | |
| HBIO Harvard Bioscience | Maintains: Speculative Buy | $45 → $30 | $5.25 | +471.43% | 6 | May 13, 2025 | |
| CLNN Clene | Maintains: Buy | $84 → $33 | $6.90 | +378.26% | 8 | May 8, 2025 | |
| GNLX Genelux | Maintains: Speculative Buy | $25 → $23 | $2.90 | +693.10% | 7 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $143.62 | -44.30% | 9 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $2.14 | - | 3 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $30 | $8.23 | +264.52% | 8 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $1.25 | $0.33 | +278.79% | 2 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $3 | $0.63 | +375.96% | 3 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $0.98 | +410.15% | 4 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $60 | $1.57 | +3,721.66% | 5 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $24 | $0.73 | +3,185.87% | 3 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $150 | $3.52 | +4,161.36% | 4 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.65 | - | 7 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $32.29 | - | 7 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Speculative Buy | $800 | $1.86 | +42,846.10% | 1 | Aug 8, 2022 |
Tandem Diabetes Care
May 12, 2026
Initiates: Hold
Price Target: n/a
Current: $12.87
Upside: -
MiniMed Group
May 12, 2026
Initiates: Buy
Price Target: $20
Current: $10.83
Upside: +84.67%
NeoGenomics
Apr 29, 2026
Upgrades: Buy
Price Target: $11
Current: $8.27
Upside: +33.01%
CapsoVision
Mar 27, 2026
Maintains: Speculative Buy
Price Target: $14 → $10
Current: $6.89
Upside: +45.14%
Abbott Laboratories
Oct 10, 2025
Initiates: Buy
Price Target: $145
Current: $84.26
Upside: +72.09%
Biofrontera
May 19, 2025
Maintains: Buy
Price Target: $7 → $2.75
Current: $0.95
Upside: +189.41%
Humacyte
May 14, 2025
Maintains: Buy
Price Target: $17 → $14
Current: $0.92
Upside: +1,428.38%
Harvard Bioscience
May 13, 2025
Maintains: Speculative Buy
Price Target: $45 → $30
Current: $5.25
Upside: +471.43%
Clene
May 8, 2025
Maintains: Buy
Price Target: $84 → $33
Current: $6.90
Upside: +378.26%
Genelux
May 8, 2025
Maintains: Speculative Buy
Price Target: $25 → $23
Current: $2.90
Upside: +693.10%
Mar 26, 2025
Reiterates: Buy
Price Target: $80
Current: $143.62
Upside: -44.30%
Nov 22, 2024
Reiterates: Hold
Price Target: n/a
Current: $2.14
Upside: -
Nov 22, 2024
Reiterates: Speculative Buy
Price Target: $30
Current: $8.23
Upside: +264.52%
Nov 20, 2024
Reiterates: Speculative Buy
Price Target: $1.25
Current: $0.33
Upside: +278.79%
Oct 11, 2024
Reiterates: Speculative Buy
Price Target: $3
Current: $0.63
Upside: +375.96%
Oct 10, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $0.98
Upside: +410.15%
Aug 27, 2024
Reiterates: Speculative Buy
Price Target: $60
Current: $1.57
Upside: +3,721.66%
Aug 14, 2024
Reiterates: Speculative Buy
Price Target: $24
Current: $0.73
Upside: +3,185.87%
Mar 21, 2024
Reiterates: Speculative Buy
Price Target: $150
Current: $3.52
Upside: +4,161.36%
Nov 14, 2023
Downgrades: Hold
Price Target: n/a
Current: $0.65
Upside: -
Sep 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $32.29
Upside: -
Aug 8, 2022
Initiates: Speculative Buy
Price Target: $800
Current: $1.86
Upside: +42,846.10%